Tdap (Tetanus, Diphtheria, Pertussis) Vaccine
Tdap vaccine protects against tetanus, diphtheria, and pertussis.
One dose of Tdap is recommended for adolescents aged 11 or 12 years in
place of one Td booster. Tdap vaccine is also recommended for older
adolescents and adults aged 13-64 years.
Washington State is currently supplying:
- GlaxoSmithKline Tdap vaccine, brand name, Boostrix. The vaccine has
normal availability.
- Sanofi Pasteur Td vaccine, brand name, Decavac, for children less
than age 19. The vaccine has normal availability.
Immunization Guidelines
for the Use of State-Supplied Vaccine (PDF, 82 KB) August 20,
2009
Vaccine Management - Recommendation for Storage and Handling of
Vaccines
Vaccine Information Statements:
Related Information:
-
Department of Health Tdap Implementation Plan
(PDF, 34 KB)
-
Vaccine Advisory Committee Recommendation for Use of
Tdap Vaccine for Adults and Adolescents (PDF,
21 KB)
-
Preventing Tetanus, Diphtheria, and Pertussis Among
Adults: Use of Tetanus Toxoid, Reduced Diphtheria
Toxoid and Acellular Pertussis Vaccine
-
Preventing Tetanus, Diphtheria, and Pertussis Among
Adolescents: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid, and Acellular Pertussis Vaccines
-
Tdap School Requirements Frequently Asked Questions
(PDF, 32 KB)
-
Prevention of Pertussis, Tetanus, and Diphtheria
Among Pregnant and Postpartum Women and Their
Infants
External Resources:
Last Update:
10/12/2009 03:50 PM
